UnitedHealth Group Incorporated (UNH) Stock Rating Reaffirmed by Leerink Swann
UnitedHealth Group Incorporated (NYSE:UNH)‘s stock had its “buy” rating reiterated by research analysts at Leerink Swann in a research report issued to clients and investors on Wednesday. They currently have a $240.00 price objective on the healthcare conglomerate’s stock, up from their previous price objective of $225.00. Leerink Swann’s target price points to a potential upside of 18.08% from the stock’s current price. Leerink Swann also issued estimates for UnitedHealth Group’s Q4 2017 earnings at $2.51 EPS, FY2017 earnings at $10.00 EPS, FY2019 earnings at $12.50 EPS and FY2020 earnings at $14.45 EPS.
Other equities research analysts have also issued research reports about the company. Citigroup Inc. increased their price target on UnitedHealth Group from $195.00 to $213.00 and gave the stock a “buy” rating in a research note on Wednesday, July 19th. Cantor Fitzgerald reiterated a “buy” rating and issued a $205.00 price target on shares of UnitedHealth Group in a research note on Friday, July 7th. Stifel Nicolaus reiterated a “buy” rating and issued a $185.00 price target on shares of UnitedHealth Group in a research note on Wednesday, June 28th. BidaskClub lowered UnitedHealth Group from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, July 19th. Finally, Mizuho set a $235.00 price target on UnitedHealth Group and gave the stock a “buy” rating in a research note on Tuesday, July 18th. Three analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $215.27.
UnitedHealth Group (NYSE UNH) traded up 1.28% during midday trading on Wednesday, reaching $205.85. The company had a trading volume of 1,067,878 shares. The company has a market capitalization of $203.59 billion, a price-to-earnings ratio of 23.37 and a beta of 0.63. UnitedHealth Group has a 52 week low of $133.03 and a 52 week high of $207.80. The firm has a 50-day moving average price of $197.17 and a 200-day moving average price of $185.63.
UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. The business had revenue of $50.32 billion during the quarter, compared to analyst estimates of $50.38 billion. During the same quarter in the prior year, the business posted $2.17 EPS. UnitedHealth Group’s revenue for the quarter was up 8.7% compared to the same quarter last year. Analysts expect that UnitedHealth Group will post $9.91 EPS for the current fiscal year.
In related news, insider Larry C. Renfro sold 50,574 shares of the stock in a transaction dated Friday, September 15th. The shares were sold at an average price of $198.11, for a total value of $10,019,215.14. Following the sale, the insider now directly owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Richard T. Burke sold 15,000 shares of the stock in a transaction dated Monday, August 21st. The stock was sold at an average price of $191.71, for a total transaction of $2,875,650.00. Following the completion of the sale, the director now directly owns 1,818,898 shares in the company, valued at $348,700,935.58. The disclosure for this sale can be found here. Insiders sold a total of 76,174 shares of company stock worth $14,981,909 over the last three months. 0.89% of the stock is currently owned by corporate insiders.
A number of institutional investors have recently bought and sold shares of UNH. Waldron LP raised its position in UnitedHealth Group by 153.1% in the 1st quarter. Waldron LP now owns 5,765 shares of the healthcare conglomerate’s stock worth $944,000 after purchasing an additional 3,487 shares during the period. WASHINGTON TRUST Co purchased a new stake in UnitedHealth Group in the 1st quarter worth about $235,000. Blue Fin Capital Inc. purchased a new stake in UnitedHealth Group in the 1st quarter worth about $205,000. Webster Bank N. A. raised its position in UnitedHealth Group by 27.0% in the 1st quarter. Webster Bank N. A. now owns 913 shares of the healthcare conglomerate’s stock worth $149,000 after purchasing an additional 194 shares during the period. Finally, Adell Harriman & Carpenter Inc. raised its position in UnitedHealth Group by 36.3% in the 1st quarter. Adell Harriman & Carpenter Inc. now owns 13,096 shares of the healthcare conglomerate’s stock worth $2,148,000 after purchasing an additional 3,485 shares during the period. 86.11% of the stock is currently owned by institutional investors.
About UnitedHealth Group
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with Analyst Ratings Network's FREE daily email newsletter.